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Background: Percutaneous catheter based replacement of the aortic valve (PAVR) is an emerging technique to treat patients with high risk for 
conventional heart surgery. Morphological parameters predicting procedural complications and clinical outcome are not well studied yet. The aim 
of the present study was to investigate the influence of aortic valve calcification as determined by Multi Slice CT on peri and post- procedural 
complications and clinical outcome.
Methods: We performed cardiac MSCT exams (Brilliance 64, Philips Medical, Hamburg) in 54 consecutive patients (73-87 years) 7-14 days prior 
to elective PAVR using the Core Valve device. Valve calcification was determined using an automatized quantification software (Philips Cardiac). All 
patients were followed up clinically and echocardiographically for 3 months.
Results: PAVR was successfully performed without MACE in 49 of 54 patients. 2 patients died during the procedure 2 died during the 3 month 
follow up period and 1 stroke occurred (MACE rate= 9,2%). These patients revealed significant more valvular calcium than patients without major 
complications (476mg± 321 vs. 899mg± 230 mg, p<0.001). Patients with postprocedural and persisting aortic regurgitation (AR) >grade 2 
(n=5/54) also revealed a larger calcium mass compared to those with no or moderate AR ( 911mg± 311 vs. 615mg± 312 vs. 198mg± 188, p< 
0.004). The likelihood for MACE and significant AR in patients with valvular calcium >800 mg was 33% (3/9) and 44% (4/9) respectively. 14 of 54 
(26%) patients required permanent pacemaker implantation after PAVR. In these patients we observed less valvular calcium than in those without 
conduction abnormalities (302mg vs. 655mg, p<0.03). The likelihood to be pacemaker dependent after PAVR was 75% (3/4) in patients with 
<200mg valvular calcium.
Conclusions: The results of the current study demonstrate that the amount of aortic valvular calcium determined by MSCT is a strong predictor for 
procedure related MACE and postprocedural AR. In contrast to these observations calcium seems to have a protective role for the conduction system 
as patients with only little valvular calcium have a high likelihood to require a permanent pacemaker after PAVR.
